POP-OUT | CLOSE
 
 
1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
 
MIX is found in 4 entries
MIX
  •   Chemical Component Summary   Hide
    Name 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE
    Identifiers 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione
    1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione
    Synonyms MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2
    -HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE
    Formula C22 H28 N4 O6
    Molecular Weight 444.48 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key KKZJGLLVHKMTCM-UHFFFAOYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01204   (Stereoisomeric match)
    Name Mitoxantrone
    Groups
    • approved
    • investigational
    Description An anthracenedione-derived antineoplastic agent. [PubChem]
    Synonyms
    • 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione
    • Mitoxantrona
    • Mitoxantrone
    • Mitoxantronum
    Salts Mitoxantrone hydrochloride
    Brand names Novantrone
    Affected organism Humans and other mammals
    Indication For the treatment of secondary (chronic) progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis
    Pharmacology Mitoxantrone has been shown in vitro to inhibit B cell, T cell, and macrophage proliferation and impair antigen presentation, as well as the secretion of interferon gamma, TNFa, and IL-2.
    Mechanism of action Mitoxantrone, a DNA-reactive agent that intercalates into deoxyribonucleic acid (DNA) through hydrogen bonding, causes crosslinks and strand breaks. Mitoxantrone also interferes with ribonucleic acid (RNA) and is a potent inhibitor of topoisomerase II, an enzyme responsible for uncoiling and repairing damaged DNA. It has a cytocidal effect on both proliferating and nonproliferating cultured human cells, suggesting lack of cell cycle phase specificity.
    Route of administration Intravenous
    Categories
    • Antineoplastic Agents
    • Analgesics
    AHFS-Code 10:00.00
    CAS number 65271-80-9
    Targets
    Name Sequence search Pharmacological action Actions
    DNA topoisomerase 2-alpha   Search  yes inhibitor
    DNA topoisomerase 2-alpha   Search  yes inhibitor
     
Ligand Image